Janus Nano-Assembly Based Sensing Platform for Cancer Theranostics: An Unrivaled Mastering Bioimaging Perspective

This study aims to explore the design, synthesis, and applications of Janus nanoparticles in the field of cancer theranostics. Janus nanoparticles, named after the two-faced Roman god Janus, possess distinct sides or regions that enable multifunctionality and versatility in cancer therapy and diagnostics. This study investigates the potential of Janus nanoparticles for targeted drug delivery, molecular imaging, and personalized medicine approaches in cancer treatment. The research focuses on addressing challenges related to stability, biocompatibility, scalability, and clinical evaluation, aiming to overcome these barriers for the successful translation of Janus nanoparticles into clinical practice. Targeted cancer theranostics, involving concurrent therapeutic treated and selective imaging of malignant tissue, has recently emerged as a potent method for enhancing patient prognosis. Targeted multimodal molecular imaging has garnered attention by overcoming specific limitations of conventional imagining modalities. In the current era, the quest to develop suitable bio-based materials and nano-scaled colloidal particulates for established application domains has resulted in notable efforts in the advancement of controlled size and shape, anisotropy, and features of nanostructures, in which the building blocks are designed via random self-assembly. It is also noteworthy to mention that salient features including multiple imaging methods to screening and diagnosis, as well as the integration of imaging elements into JNPs (such as quantum dots and fluorescent dyes) could be accomplished. State-of-the-art developments in JNPs, including their classification and the performance of fabric nanoparticles in cancer theranostics, are also covered. This study will outline the primary production strategies as well as major advancements of JNPs paving way in the biomedical and cancer therapy.